124 related articles for article (PubMed ID: 7529808)
21. Do plasma anti phospholipid antibodies in patients with autoimmune haemolytic anaemia correlate with reduced levels of erythrocyte complement receptor 1?
Jones DR; Scarsbrook AF; Imrie H; Booker D; Sokol RJ
Autoimmunity; 1996; 23(1):45-51. PubMed ID: 8871761
[TBL] [Abstract][Full Text] [Related]
22. Disease-associated loss of erythrocyte complement receptors (CR1, C3b receptors) in patients with systemic lupus erythematosus and other diseases involving autoantibodies and/or complement activation.
Ross GD; Yount WJ; Walport MJ; Winfield JB; Parker CJ; Fuller CR; Taylor RP; Myones BL; Lachmann PJ
J Immunol; 1985 Sep; 135(3):2005-14. PubMed ID: 4020137
[TBL] [Abstract][Full Text] [Related]
23. Levels of complement regulatory molecules in lung cancer: disappearance of the D17 epitope of CD55 in small-cell carcinoma.
Sakuma T; Kodama K; Hara T; Eshita Y; Shibata N; Matsumoto M; Seya T; Mori Y
Jpn J Cancer Res; 1993 Jul; 84(7):753-9. PubMed ID: 7690355
[TBL] [Abstract][Full Text] [Related]
24. Modulation of urinary CR1 in systemic lupus erythematosus.
Sivasankar B; Dinda AK; Tiwari SC; Srivastava LM; Das N
Lupus; 2004; 13(4):228-33. PubMed ID: 15176657
[TBL] [Abstract][Full Text] [Related]
25. Proteolytic cleavage of CR1 on human erythrocytes in vivo: evidence for enhanced cleavage in AIDS.
Pascual M; Danielsson C; Steiger G; Schifferli JA
Eur J Immunol; 1994 Mar; 24(3):702-8. PubMed ID: 7510241
[TBL] [Abstract][Full Text] [Related]
26. Aberrant expression of membrane cofactor protein and decay-accelerating factor in the endothelium of patients with systemic sclerosis. A possible mechanism of vascular damage.
Venneker GT; van den Hoogen FH; Boerbooms AM; Bos JD; Asghar SS
Lab Invest; 1994 Jun; 70(6):830-5. PubMed ID: 7516986
[TBL] [Abstract][Full Text] [Related]
27. CR1 on erythrocytes of Brazilian systemic lupus erythematosus patients: the influence of disease activity on expression and ability of this receptor to bind immune complexes opsonized with complement from normal human serum.
Marzocchi-Machado CM; Alves CM; Azzolini AE; Polizello AC; Carvalho IF; Lucisano-Valim YM
J Autoimmun; 2005 Dec; 25(4):289-97. PubMed ID: 16289666
[TBL] [Abstract][Full Text] [Related]
28. Expression of complement regulatory proteins on islets of Langerhans: a comparison between human islets and islets isolated from normal and hDAF transgenic pigs.
Bennet W; Björkland A; Sundberg B; Brandhorst D; Brendel MD; Richards A; White DJ; Nilsson B; Groth CG; Korsgren O
Transplantation; 2001 Jul; 72(2):312-9. PubMed ID: 11477359
[TBL] [Abstract][Full Text] [Related]
29. Expression of the complement regulatory proteins CD21, CD55 and CD59 on Burkitt lymphoma lines: their role in sensitivity to human serum-mediated lysis.
Kuraya M; Yefenof E; Klein G; Klein E
Eur J Immunol; 1992 Jul; 22(7):1871-6. PubMed ID: 1378022
[TBL] [Abstract][Full Text] [Related]
30. Expression of CD55 and CD59 on peripheral blood cells from systemic lupus erythematosus (SLE) patients.
Alegretti AP; Mucenic T; Merzoni J; Faulhaber GA; Silla LM; Xavier RM
Cell Immunol; 2010; 265(2):127-32. PubMed ID: 20727519
[TBL] [Abstract][Full Text] [Related]
31. Deficiency of an erythrocyte membrane protein with complement regulatory activity in paroxysmal nocturnal hemoglobinuria.
Pangburn MK; Schreiber RD; Müller-Eberhard HJ
Proc Natl Acad Sci U S A; 1983 Sep; 80(17):5430-4. PubMed ID: 6225118
[TBL] [Abstract][Full Text] [Related]
32. X-irradiation does not affect the levels of complement regulatory proteins, CD35 (CR1), CD55 (DAF) and CD59 on concentrated red cells.
Fukumori Y; Seya T; Ohnoki S; Shibata H; Yamaguchi H
Vox Sang; 1996; 71(4):243-4. PubMed ID: 8958650
[No Abstract] [Full Text] [Related]
33. An enzyme based assay for the measurement of complement mediated binding of immune complexes to red blood cells.
Rafnar BO; Traustadóttir KH; Sigfússon A; Arason GJ; Valdimarsson H; Erlendsson K
J Immunol Methods; 1998 Feb; 211(1-2):171-81. PubMed ID: 9617841
[TBL] [Abstract][Full Text] [Related]
34. The quantification of C3 fragments on erythrocytes: estimation of C3 fragments on normal cells, acquired haemolytic anaemia cases and correlation with agglutination of sensitized cells.
Merry AH; Thomson EE; Rawlinson VI; Stratton F
Clin Lab Haematol; 1983; 5(4):387-97. PubMed ID: 6607814
[TBL] [Abstract][Full Text] [Related]
35. Expression of complement-regulatory proteins in normal and UW-preserved human liver.
Scoazec JY; Delautier D; Moreau A; Durand F; Degott C; Benhamou JP; Belghiti J; Feldmann G
Gastroenterology; 1994 Aug; 107(2):505-16. PubMed ID: 7518785
[TBL] [Abstract][Full Text] [Related]
36. The significance of complement on the red cell surface.
Freedman J
Transfus Med Rev; 1987 Apr; 1(1):58-70. PubMed ID: 2980267
[No Abstract] [Full Text] [Related]
37. Advances in the development of a reliable assay for the measurement of stool decay-accelerating factor in the detection of colorectal cancer.
Iwagaki N; Mizuno M; Nasu J; Mizuno M; Okazaki H; Hori S; Yamamoto K; Okada H; Tsuji T; Fujita T; Shiratori Y
J Immunoassay Immunochem; 2002; 23(4):497-507. PubMed ID: 12458732
[TBL] [Abstract][Full Text] [Related]
38. Protease-modified erythrocytes: CD55 and CD59 deficient PNH-like cells.
Yuan FF; Bryant JA; Fletcher A
Immunol Cell Biol; 1995 Feb; 73(1):66-72. PubMed ID: 7539403
[TBL] [Abstract][Full Text] [Related]
39. Expression of the DAF (CD55) and CD59 antigens during normal hematopoietic cell differentiation.
Terstappen LW; Nguyen M; Lazarus HM; Medof ME
J Leukoc Biol; 1992 Dec; 52(6):652-60. PubMed ID: 1281489
[TBL] [Abstract][Full Text] [Related]
40. Erythrocyte complement receptor type 1 in patients with systemic lupus erythematosus.
Yen JH; Liu HW; Lin SF; Chen JR; Chen TP
J Rheumatol; 1989 Oct; 16(10):1320-5. PubMed ID: 2810256
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
